A 6-year-old boy presented with a 2-year history of recurrent episodes of painful, haemorrhagic vesicles and erythema affecting the face, ears and neck, 2 hours after sun exposure ([figures 1 and 2](#F1 F2){ref-type="fig"}). He had severe ulceration and crusting affecting the helix of his ear ([figure 3](#F3){ref-type="fig"}). Healing was accompanied by residual varioliform, atrophic scarring ([figure 4](#F4){ref-type="fig"}). His rash occurred during spring and summer months and only affected sun-exposed sites.

![Tender erythematous vesicles and papules with haemorrhage and crusting arising 2 hours after sun exposure.](archdischild-2018-316272f01){#F1}

![Tender erythematous vesicles and papules with haemorrhage and crusting arising 2 hours after sun exposure.](archdischild-2018-316272f02){#F2}

![Severe ulceration and crusting affecting the helix of his ear.](archdischild-2018-316272f03){#F3}

![Resolving eruption and residual varioliform, atrophic scarring.](archdischild-2018-316272f04){#F4}

He was referred for investigation in a photodermatology unit, which showed positive provocation of his rash with broadband ultraviolet (UV) radiation and reduced phototest thresholds at 350--370 nm wavelengths, confirming the presence of UVA photosensitivity. Epstein-Barr virus (EBV) IgG was positive. His connective tissue disease and porphyria screens were negative.

Hydroa vacciniforme is a photosensitivity disorder of childhood of unknown aetiology which leads to painful vesicular eruptions affecting sun-exposed sites, settling with haemorrhagic crusting. It tends to resolve in adolescence but can leave permanent pox-like, depressed scarring. An association has been found between hydroa vacciniforme and latent EBV infection.^1^ Management includes careful photoprotection with broad-spectrum sunscreens, sun-protective clothing and UV films for windows. Regular vitamin D replacement should be offered. Appropriate urgent referral is vital to improve quality of life and to minimise scarring.
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